New Leaf Venture Partners, L.L.C. X4 Pharmaceuticals, Inc Transaction History
New Leaf Venture Partners, L.L.C.
- $82.1 Million
- Q2 2024
A detailed history of New Leaf Venture Partners, L.L.C. transactions in X4 Pharmaceuticals, Inc stock. As of the latest transaction made, New Leaf Venture Partners, L.L.C. holds 335,000 shares of XFOR stock, worth $207,700. This represents 0.24% of its overall portfolio holdings.
Number of Shares
335,000
Previous 335,000
-0.0%
Holding current value
$207,700
Previous $465,000
58.28%
% of portfolio
0.24%
Previous 0.41%
Shares
2 transactions
Others Institutions Holding XFOR
# of Institutions
108Shares Held
101MCall Options Held
418KPut Options Held
71.7K-
Bain Capital Life Sciences Investors, LLC Boston, MA16.9MShares$10.5 Million2.01% of portfolio
-
Nea Management Company, LLC Timonium, MD15MShares$9.29 Million0.82% of portfolio
-
Black Rock Inc. New York, NY10.7MShares$6.62 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.29MShares$5.14 Million0.0% of portfolio
-
Orbimed Advisors LLC San Diego, CA7.13MShares$4.42 Million0.1% of portfolio
About X4 Pharmaceuticals, Inc
- Ticker XFOR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,646,096
- Market Cap $42.6M
- Description
- X4 Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is mavorixafor, a small molecule inhibitor of the chemokine receptor C-X-C chemokine receptor type 4 (CXCR4), which is in Phase...